City Therapeutics earnings were N/A for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest CTY earnings report on Jun 30, 2026 announced Q2 2026 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, CTY reported annual earnings of -$58.5M, with 110.2% growth.
As of the last City Therapeutics earnings report, City Therapeutics is currently losing money. City Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2026 was N/A, a N/A decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.